{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:30:42Z","timestamp":1707525042984},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,7]]},"DOI":"10.7759\/cureus.40079","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T10:32:00Z","timestamp":1686133920000},"source":"Crossref","is-referenced-by-count":0,"title":["Pathological Vertebral Fracture Arising From Methotrexate-Associated Lymphoproliferative Disorder in a Patient With Systemic Lupus Erythematosus"],"prefix":"10.7759","author":[{"given":"Takaki","family":"Kitamura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonori","family":"Shigemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuaki","family":"Murata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/0961203313519159","article-title":"Methotrexate in systemic lupus erythematosus: a systematic review of its efficacy","volume":"23","author":"Sakthiswary R","year":"2014","unstructured":"Sakthiswary R, Suresh E. Methotrexate in systemic lupus erythematosus: a systematic review of its efficacy. Lupus. 2014, 23:225-35. 10.1177\/0961203313519159","journal-title":"Lupus"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.19028","article-title":"Immune response in LPD during methotrexate administration (MTX-LPD) in rheumatoid arthritis patients","volume":"59","author":"Saito S","year":"2019","unstructured":"Saito S, Takeuchi T. Immune response in LPD during methotrexate administration (MTX-LPD) in rheumatoid arthritis patients. J Clin Exp Hematop. 2019, 59:145-55. 10.3960\/jslrt.19028","journal-title":"J Clin Exp Hematop"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.19007","article-title":"Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders","volume":"59","author":"Tokuhira M","year":"2019","unstructured":"Tokuhira M, Tamaru JI, Kizaki M. Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders. J Clin Exp Hematop. 2019, 59:72-92. 10.3960\/jslrt.19007","journal-title":"J Clin Exp Hematop"},{"key":"ref4","article-title":"Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication","volume":"34","author":"Hoshida Y","year":"2007","unstructured":"Hoshida Y, Xu JX, Fujita S, et al.. Lymphoproliferative disorders in rheumatoid arthritis: clinicopathological analysis of 76 cases in relation to methotrexate medication. J Rheumatol. 2007, 34:322-31.","journal-title":"J Rheumatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2106\/JBJS.CC.17.00002","article-title":"Methotrexate-related lymphoproliferative disorder presenting with severe swelling of the elbow joint: a case report","volume":"7","author":"Hatano T","year":"2017","unstructured":"Hatano T, Ohishi M, Yoshimoto G, et al.. Methotrexate-related lymphoproliferative disorder presenting with severe swelling of the elbow joint: a case report. JBJS Case Connect. 2017, 7:e65. 10.2106\/JBJS.CC.17.00002","journal-title":"JBJS Case Connect"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhsa.2006.05.003","article-title":"An unusual presentation of methotrexate-induced B-cell lymphoma of the metacarpophalangeal joint: a case report and literature review","volume":"31","author":"Kennedy JW","year":"2006","unstructured":"Kennedy JW, Wong LK, Kalantarian B, Turner L, Hayes CW. An unusual presentation of methotrexate-induced B-cell lymphoma of the metacarpophalangeal joint: a case report and literature review. J Hand Surg Am. 2006, 31:1193-6. 10.1016\/j.jhsa.2006.05.003","journal-title":"J Hand Surg Am"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.3171\/2018.4.SPINE1860","article-title":"Methotrexate-related lymphoproliferative disorder of the lumbar spine origin presenting with severe low-back pain: case report","volume":"29","author":"Kikuchi N","year":"2018","unstructured":"Kikuchi N, Uesugi M, Koda M, et al.. Methotrexate-related lymphoproliferative disorder of the lumbar spine origin presenting with severe low-back pain: case report. J Neurosurg Spine. 2018, 29:545-8. 10.3171\/2018.4.SPINE1860","journal-title":"J Neurosurg Spine"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00256-021-03764-1","article-title":"Methotrexate-associated lymphoproliferative disorder of the thoracic spine in a patient with rheumatoid arthritis receiving methotrexate: a case report","volume":"50","author":"Kamio S","year":"2021","unstructured":"Kamio S, Anazawa U, Watanabe I, Sasaki A, Aoyama R. Methotrexate-associated lymphoproliferative disorder of the thoracic spine in a patient with rheumatoid arthritis receiving methotrexate: a case report. Skeletal Radiol. 2021, 50:2117-23. 10.1007\/s00256-021-03764-1","journal-title":"Skeletal Radiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3960\/jslrt.56.165","article-title":"The aggressive clinical courses of Hodgkin lymphoma primarily diagnosed as methotrexate-induced non-specific lymphoproliferative disorder in patients with rheumatoid arthritis","volume":"56","author":"Tokuhira M","year":"2017","unstructured":"Tokuhira M, Tabayashi T, Tanaka Y, et al.. The aggressive clinical courses of Hodgkin lymphoma primarily diagnosed as methotrexate-induced non-specific lymphoproliferative disorder in patients with rheumatoid arthritis. J Clin Exp Hematop. 2017, 56:165-9. 10.3960\/jslrt.56.165","journal-title":"J Clin Exp Hematop"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.13107\/jocr.2021.v11.i03.2090","article-title":"Recurrent methotrexate-related lymphoproliferative disorder of the lumbar spine origin: a case report","volume":"11","author":"Okuwaki S","year":"2021","unstructured":"Okuwaki S, Uesugi M, Koda M, Kikuchi N, Yamazaki M. Recurrent methotrexate-related lymphoproliferative disorder of the lumbar spine origin: a case report. J Orthop Case Rep. 2021, 11:63-6. 10.13107\/jocr.2021.v11.i03.2090","journal-title":"J Orthop Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.27692","article-title":"Methotrexate-associated lymphoproliferative disease of the thoracic spine misdiagnosed as metastatic spinal tumor: a case report","volume":"14","author":"Tsukamoto M","year":"2022","unstructured":"Tsukamoto M, Morimoto T, Hirata H, Yoshihara T, Mawatari M. Methotrexate-associated lymphoproliferative disease of the thoracic spine misdiagnosed as metastatic spinal tumor: a case report. Cureus. 2022, 14:e27692. 10.7759\/cureus.27692","journal-title":"Cureus"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-008-9069-8","article-title":"Spontaneous remission of \"methotrexate-associated lymphoproliferative disorders\" after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature","volume":"26","author":"Rizzi R","year":"2009","unstructured":"Rizzi R, Curci P, Delia M, Rinaldi E, Chiefa A, Specchia G, Liso V. Spontaneous remission of \"methotrexate-associated lymphoproliferative disorders\" after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature. Med Oncol. 2009, 26:1-9. 10.1007\/s12032-008-9069-8","journal-title":"Med Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00264-013-2055-6","article-title":"Primary lymphoma of bone: outcome and role of surgery","volume":"37","author":"Scoccianti G","year":"2013","unstructured":"Scoccianti G, Rigacci L, Puccini B, Campanacci DA, Simontacchi G, Bosi A, Capanna R. Primary lymphoma of bone: outcome and role of surgery. Int Orthop. 2013, 37:2437-42. 10.1007\/s00264-013-2055-6","journal-title":"Int Orthop"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000031993","article-title":"Primary hepatic methotrexate-associated lymphoproliferative disorder associated with Epstein-Barr virus reactivation and accompanied by spontaneous necrosis: a case report","volume":"101","author":"Omameuda T","year":"2022","unstructured":"Omameuda T, Miyato H, Sata N, Lefor AK. Primary hepatic methotrexate-associated lymphoproliferative disorder associated with Epstein-Barr virus reactivation and accompanied by spontaneous necrosis: a case report. Medicine (Baltimore). 2022, 101:e31993. 10.1097\/MD.0000000000031993","journal-title":"Medicine (Baltimore)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2018.1654","article-title":"Lymphoproliferative disorder with pathological fracture of the femur in a patient with rheumatoid arthritis treated with methotrexate: a case report","volume":"9","author":"Oebisu N","year":"2018","unstructured":"Oebisu N, Hoshi M, Ieguchi M, Iwai T, Tanaka S, Osawa M, Nakamura H. Lymphoproliferative disorder with pathological fracture of the femur in a patient with rheumatoid arthritis treated with methotrexate: a case report. Mol Clin Oncol. 2018, 9:187-91. 10.3892\/mco.2018.1654","journal-title":"Mol Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/160732-pathological-vertebral-fracture-arising-from-methotrexate-associated-lymphoproliferative-disorder-in-a-patient-with-systemic-lupus-erythematosus","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:00:17Z","timestamp":1707508817000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/160732-pathological-vertebral-fracture-arising-from-methotrexate-associated-lymphoproliferative-disorder-in-a-patient-with-systemic-lupus-erythematosus"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,7]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.40079","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,7]]}}}